Page last updated: 2024-10-27

flurbiprofen and Abnormalities, Congenital

flurbiprofen has been researched along with Abnormalities, Congenital in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pan, Y1
Wang, Y1
Lie, D1
Liu, D1
Chen, X1
Wu, Z1
Chen, L1
Wang, H1
Peng, L1
Liang, H1
Song, X1
Zhao, B1

Trials

1 trial available for flurbiprofen and Abnormalities, Congenital

ArticleYear
Effectiveness of analgesia with hydromorphone hydrochloride for postoperative pain following surgical repair of structural congenital malformations in children: a randomized controlled trial.
    BMC anesthesiology, 2021, 07-16, Volume: 21, Issue:1

    Topics: Analgesics, Opioid; Anesthesia, General; Child, Preschool; Congenital Abnormalities; Dose-Response R

2021